The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2018
DOI: 10.1016/j.jsps.2017.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Effect of combined gliclazide/metformin treatment on oxidative stress, lipid profile, and hepatorenal functions in type 2 diabetic patients

Abstract: Oxidative stress, lipids profile, and hepatorenal functions were not different in patients who were on combined metformin/gliclazide therapy and compared to those metformin alone. In contrast, glycemic control was poor in the diabetic patients undergoing combined therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 28 publications
0
18
0
Order By: Relevance
“…Furthermore, studies are also required to explore the relevant mechanism. For patients at an early stage of AP, the severity and importance of organs involved in the injuries are more than the pancreas itself (Liu et al, 2006, Dos Santos et al, 2018, Alsharidah et al, 2018, Yildiz et al, 2017, Pati et al, 2017, Tatar et al, 2017), while multi-organ injuries are strongly associated with the inflammatory responses caused by hyperglycemia. Thus, in clinical treatment of AP, great attention should be paid to the glucose level, and rational control of glucose might be critical to the development and treatment of AP through affecting the inflammatory responses.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, studies are also required to explore the relevant mechanism. For patients at an early stage of AP, the severity and importance of organs involved in the injuries are more than the pancreas itself (Liu et al, 2006, Dos Santos et al, 2018, Alsharidah et al, 2018, Yildiz et al, 2017, Pati et al, 2017, Tatar et al, 2017), while multi-organ injuries are strongly associated with the inflammatory responses caused by hyperglycemia. Thus, in clinical treatment of AP, great attention should be paid to the glucose level, and rational control of glucose might be critical to the development and treatment of AP through affecting the inflammatory responses.…”
Section: Discussionmentioning
confidence: 99%
“…Diabetes mellitus is a complex metabolic disorder characterized by hyperglycemia, pancreatic beta (β) cells dysfunction, and abnormal lipid profile that result from metabolic deregulations, impaired insulin secretion and action, and inappropriate consumption of glucose [1]. It is one of the most prevalent chronic diseases and leads towards severe complications such as increase in production of reactive oxygen species (ROS), impairment of antioxidant enzymes [2], hyperglycemia [3], dislipidemia [4], alteration in insulin signaling pathway, and ROS-induced cellular damage [5]. All these changes will result in diabetes-associated secondary complications like nephropathy, retinopathy, neuropathy, and cardiovascular morbidity [6].…”
Section: Introductionmentioning
confidence: 99%
“…Diabetes mellitus is characterized by disturbed metabolism and a marked hyperglycaemia due to abnormal release and peripheral utilization of insulin hormone. This disease leads to multiple complications like increase in reactive oxygen species (Chen et al, 2018), impairment of scavenging enzymes (Choi and Ho, 2018), abnormal lipid profile (Alsharidah et al, 2017), hyperglycemia (Perry et al, 2018), impaired insulin secretion and action (Khan et al, 2009) and cellular damage induced by high oxidative stress (Capellini et al, 2010).…”
Section: Introductionmentioning
confidence: 99%